Max Healthcare Institute has announced that the Competition Commission of India (CCI) has issued separate orders favouring its network hospitals, concluding that no case of abuse of dominant position under Section 4 of the Competition Act, 2002, is made out against them. This decision effectively closes the matter with no adverse orders.
The CCI’s orders, dated May 21, 2026, come after a thorough review of the supplementary investigation report filed by the Director General (DG), along with objections, oral arguments, and written submissions from the hospitals involved. The investigation initially stemmed from a directive issued on August 31, 2018, which called for a re-investigation into the healthcare industry concerning the pricing of medicines, packages, and consumables by respondent hospitals in Delhi, including six Max Network Hospitals.
The orders were received by Max Healthcare on May 21, 2026, at 9:47 pm IST, and are also accessible on the CCI’s official website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).